Gladwin Das

Biography

Dr. Das completed his general- and interventional-cardiology fellowships at the University of Minnesota, joined the faculty in 1994, and served as the medical director of interventional cardiology and cardiac catheterization from 2005-February 2010. As director of the cardiac catheterization laboratory, Dr. Das established a Level I STEMI program and initiated process improvements resulting in median door-to-balloon times of less than 60 minutes. In partnership with Dr. Ken Liao of the division of cardiothoracic surgery, he has pioneered a growing hybrid percutaneous coronary intervention/robotic-assisted coronary-artery bypass grafting program, which he now directs.Dr. Das holds several U.S. and international patents for transcatheter cardiac devices. Most notably, he pioneered the development of self-centering septal occluders with the Das AngelWings® device in the 1990s, and continues to work on device development in this and other areas. His concept of “true” self-centering intracardiac septal occluders has revolutionized the field, and provides minimally-invasive options for hundreds of thousands of patients worldwide.

Research Interest

Dr. Das has a special interest in the early diagnosis of acute coronary syndromes (ACS), and established the University of Minnesota Medical Center-Fairview’s Chest-Pain Center for the rapid triage and management of ACS patients. Focused on interventional cardiology, his clinical practice encompasses patients with coronary-artery disease or structural heart disease, including a special emphasis on transcatheter repair of cardiac septal defects. He is a co-PI for the national BARI 2D study.